ID   HEV0213
AC   CVCL_T180
DR   CLO; CLO_0051289
DR   RCB; HEV0213
DR   Wikidata; Q54883072
RX   PubMed=16260175;
CC   Population: Japanese.
CC   HLA typing: A*02:18,33:03; B*44:03,46:01; C*01:02,14:03; DPB1*02:01,02:02; DQB1*04:01,06:01; DRB1*04:05,08:03 (RCB=HEV0213).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   64Y
CA   Transformed cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 10
//
RX   PubMed=16260175; DOI=10.1016/j.mrgentox.2005.07.012;
RA   Iwakawa M., Goto M., Noda S., Sagara M., Yamada S., Yamamoto N.,
RA   Kawakami Y., Matsui Y., Miyazawa Y., Yamazaki H., Tsuji H., Ohno T.,
RA   Mizoe J., Tsujii H., Imai T.;
RT   "DNA repair capacity measured by high throughput alkaline comet assays
RT   in EBV-transformed cell lines and peripheral blood cells from cancer
RT   patients and healthy volunteers.";
RL   Mutat. Res. 588:1-6(2005).
//